Product Code: RP-ID-10151824 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10151824
Market Overview:
Global Angiongenesis Inhibitors and Stimulators Industry Market Research 2022-2030
"Angiogenesis is the physiological process of forming new blood vessels from existing ones. Angiogenesis is generally divided into two types: vegetative angiogenesis and neovascularization. Angiogenesis is the basic mechanism of angiogenesis in which the formation of new blood vessels is controlled in successive steps. Angiogenesis is a disease in which existing blood vessels divide to form new blood vessels (also called mitotic angiogenesis). Unlike angiogenesis, co-development does not require local proliferation of endothelial cells. Angiogenesis is mainly associated with various diseases such as age-related macular degeneration, rheumatoid arthritis, cancer, and psoriasis. Blood vessels stimulated by angiogenesis.
Avastin (bevacizumab), Griuk, Tarture and Ilsa are the most important angiogenesis inhibitors in the world. The increase in cancer cases during the forecast period will drive the growth of this market as research and development activities for the production of new angiogenic drugs for cancer treatment are at a top level.
According to the World Health Organization (WHO), an estimated 8.2 million people died from cancer in 2012. The annual incidence of cancer is projected to increase from 14 million to 22 million per year over the next 20 years.
Additionally, the National Cancer Institute reported approximately 1,660,290 cases in the United States in 2013 and said technological advances will drive the growth of the angiogenesis inhibitors and inducers market. Thus, angiogenesis studies have enabled the identification of various vascular agonists and antagonists. However, the high cost of these drugs limits the growth of this market.
Geographically, North America is the largest market for angiogenesis inhibitors and stimulants, followed by Europe, because of the large patient base in these regions and the increasing population seeking treatment. The market for angiogenesis inhibitors and stimulants in Asia-Pacific countries such as India and China, and Southeast Asian countries is growing strongly because the total number of newly diagnosed cancer patients in the region has increased. According to the World Health Organization, 60% of the total annual global cancer cases occur in Africa, Asia and South America.
Some of the major players in the angiogenesis inhibitor and stimulant market are Abbott Laboratories, Adnexus Therapeutics, Inc., F. Hoffman-La Roche, Ltd., Genentech, Inc., Amgen, Inc., AstraZeneca Plc., Novartis AG, Pfizer., Inc., Chugai Pharmaceutical Co., Ltd., EntreMed, Inc. and Eyetech, Inc. Our main support is the four-quadrant framework EIRS, which provides detailed four-element visualization: Customer experience map Data-based research information and tools Actionable results that meet all business priorities Strategic framework for driving customer journey growth1.
Customer Experience Map This study provides an in-depth evaluation of various customer journeys related to the market and its market segments. It provides various customer impressions of products and services used. This analysis will carefully study your pain points and fears at various points in contact with customers. Consulting and business intelligence solutions will help stakeholders, including CXO, define a customer experience map that suits their needs.
This will help them aim to drive customer interaction with their brand. Insights and tools Various insights into research are based on a careful cycle of primary and secondary research that analysts participate in during the investigation process. Analysts and consultants use quantitative customer knowledge tools and industry-wide market forecasting methods to provide results and make them reliable. The research not only provided estimates and forecasts, but also cleverly evaluated these numbers about market dynamics. These insights combine a data-driven research framework with qualitative surveys of business owners, chief operating officers, policy makers, and investors.
These insights will also help your customers overcome their fears. Actionable results findings in this study are indispensable guidelines for meeting all business priorities, including mission-critical priorities. After implementation, the results provide tangible benefits for business stakeholders and industry entities to drive their performance.
The results are tailored according to the personal strategic framework. The research also illustrates some recent case studies about solving various problems faced by companies in the integration process. Strategic Framework This research enables companies and anyone interested in the market to develop a broad strategic framework. Given the current uncertainty caused by COVID-19, this has become more important than ever. The study considered negotiations to overcome some of the interruptions in the past and envisaged new interruptions to advance preparations."
Related Reports
Proof of Quality & Reliability
